Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study.

JCO precision oncology·2026
Same author

Effect of La and Ce Microalloying on the Corrosion Resistance of 0.4Sb Low-Alloy Steel in a Harsh Marine Atmospheric Environment.

Materials (Basel, Switzerland)·2026
Same author

Anti-Tumor Activity of Cdk2/9 Inhibitor Fadraciclib in an In Vivo Model of Temozolomide Refractory Neuroblastoma.

Molecular cancer therapeutics·2026
Same author

Pterostilbene mitigates intervertebral disc degeneration via dual regulation of mitophagy and NLRP3 ubiquitination to inhibit nucleus pulposus cell pyroptosis.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2026
Same author

Synthesis of Uniform 6-Armchair Graphene Nanoribbons and Their Isotope and Nitrogen-Doped Derivatives.

Angewandte Chemie (International ed. in English)·2026
Same author

Stage-Specific Regulation of DNA Damage Repair by the Circadian Regulator, CRY1, in Prostate Cancer.

bioRxiv : the preprint server for biology·2026
Same journal

Microfluidic rare cell analysis beyond counting: workflow design from enrichment to multi-omics.

Lab on a chip·2026
Same journal

A sperm racetrack to separate sperm by swim speed.

Lab on a chip·2026
Same journal

Controlled encapsulation and droplet size prediction in two-step microfluidic double emulsions.

Lab on a chip·2026
Same journal

A particulate blood-mimicking fluid with physiological biconcave geometry for microscale hemorheology.

Lab on a chip·2026
Same journal

Multicellular sensor arrays fabricated by capillary stamping for pattern-based odor discrimination.

Lab on a chip·2026
Same journal

A real-time microfluidic surveillance system for multiplex detection of heavy metal contamination in wastewater.

Lab on a chip·2026
See all related articles

Related Experiment Video

Updated: Sep 15, 2025

Zebrafish Model of Neuroblastoma Metastasis
05:20

Zebrafish Model of Neuroblastoma Metastasis

Published on: March 14, 2021

2.9K

Diagnostic technologies for neuroblastoma.

Leena Khelifa1, Yubing Hu1, Jennifer Tall2

  • 1Department of Chemical Engineering, Imperial College London, South Kensington, London, SW7 2BU, UK. yubing.hu@imperial.ac.uk.

Lab on a Chip
|July 14, 2025
PubMed
Summary
This summary is machine-generated.

Point-of-care (POC) diagnostics offer a non-invasive approach for early neuroblastoma detection. These rapid, cost-effective biosensor technologies improve risk stratification and patient outcomes by identifying biomarkers in blood or urine.

More Related Videos

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.1K
Utilization of Ultrasound Guided Tissue-directed Cellular Implantation for the Establishment of Biologically Relevant Metastatic Tumor Xenografts
07:50

Utilization of Ultrasound Guided Tissue-directed Cellular Implantation for the Establishment of Biologically Relevant Metastatic Tumor Xenografts

Published on: May 25, 2018

8.4K

Related Experiment Videos

Last Updated: Sep 15, 2025

Zebrafish Model of Neuroblastoma Metastasis
05:20

Zebrafish Model of Neuroblastoma Metastasis

Published on: March 14, 2021

2.9K
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.1K
Utilization of Ultrasound Guided Tissue-directed Cellular Implantation for the Establishment of Biologically Relevant Metastatic Tumor Xenografts
07:50

Utilization of Ultrasound Guided Tissue-directed Cellular Implantation for the Establishment of Biologically Relevant Metastatic Tumor Xenografts

Published on: May 25, 2018

8.4K

Area of Science:

  • Pediatric Oncology
  • Biomedical Engineering
  • Diagnostic Technology

Background:

  • Neuroblastoma is an aggressive childhood cancer with high relapse rates and heterogeneity.
  • Current diagnostic methods, including biopsies, cause significant patient trauma and often fail to detect tumors at early, resectable stages.
  • Existing diagnostic technologies lack the speed and non-invasive nature required for early and widespread screening.

Purpose of the Study:

  • To review advancements in neuroblastoma diagnosis, focusing on rapid, non-invasive, and cost-effective methods.
  • To highlight the potential of point-of-care (POC) diagnostic devices for early neuroblastoma detection and risk stratification.
  • To discuss the translational potential of novel biomarkers for POC applications in neuroblastoma.

Main Methods:

  • Review of recent literature on neuroblastoma diagnostic technologies, including liquid biopsy, radiomics, AI, and biosensors.
  • Analysis of emerging biomarkers such as proteomic, metabolic, and epigenetic markers (e.g., MYCN amplification, microRNAs).
  • Evaluation of the feasibility and potential of POC diagnostic devices for neuroblastoma screening.

Main Results:

  • Advancements like liquid biopsy, radiomics, AI, and biosensors are driving the development of faster, non-invasive diagnostic tools.
  • Several potential biomarkers (proteomic, metabolic, epigenetic) show promise for POC detection in biofluids.
  • POC diagnostics offer a pathway for early population-level screening and home health monitoring for neuroblastoma.

Conclusions:

  • POC diagnostic devices hold significant potential for non-invasive, early detection of neuroblastoma using biomarkers in blood and urine.
  • These technologies can facilitate early screening, risk stratification, and real-time health monitoring, improving patient outcomes.
  • Further clinical validation is needed for existing POC devices to realize their full potential in neuroblastoma diagnosis and management.